Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 181-188 , February 2001

Efficacy, safety, and use of snake antivenoms in the United States

Presented at the North American Congress of Clinical Toxicology’s “Advances in the Management of Snakebite” Symposium, October 1999, La Jolla, CA.

  • Richard C. Dart, MD, PhD

      Affiliations

    • Rocky Mountain Poison and Drug Center, Denver Health Authority, and the Department of Surgery, Medicine and Pharmacy, University of Colorado Health Sciences Center, Denver, CO
    • ,
  • Jude McNally, RPh, ABAT

      Affiliations

    • Arizona Poison and Drug Information Center, University of Arizona, Tucson, AZ.

Received 25 August 2000 ,Revised 29 November 2000 ,Accepted 5 December 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Dr. Dart and Mr. McNally were clinical investigators in the trials of the experimental antivenom described in the text and were paid speakers in the symposium “Advances in the Management of Snakebite” that was sponsored by Savage Laboratories.

☆☆ Address for reprints: Richard C. Dart, MD, PhD, Rocky Mountain Poison and Drug Center, 1010 Yosemite Circle, Denver, CO 80230; 303-739-1100, fax 303-739-1119;,E-mail rdart@rmpdc.org .

PII: S0196-0644(01)65378-2

doi: 10.1067/mem.2001.113372

Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 181-188 , February 2001

Article Tools

* Image Usage & Resolution